| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 12,380 | $30 | $420.8K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 29,070 | $10 | $290.7K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 50,400 | $1 | $201.6K |
| J9312 | Injection, rituximab, 10 mg | 2,750 | $60 | $173.4K |
| J0897 | Injection, denosumab, 1 mg | 8,160 | $20 | $146.9K |
| J3262 | Injection, tocilizumab, 1 mg | 27,280 | $10 | $136.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,130 | $90 | $106.1K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,540 | $30 | $40K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 380 | $60 | $23.7K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 350 | $50 | $17.4K |